UBT251 targets GLP-1, GIP, and a third hormone, glucagon, hence the name "triple G". Rival Eli Lilly (LLY.N), opens new tab is developing a similar drug, retatrutide, that has shown to help ...

The suspects of drug seller operated mainly through grocery stores and have now begun offering cash-on-delivery (COD) ...

This is the same mechanism as Eli Lilly’s next-generation “triple-G” drug retatrutide, which has so far appeared to be the most effective obesity drug in development.

(Reuters) -Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up to $2 billion.

(Reuters) -Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up to $2 billion.